Crossref
INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.025412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Naiem T Issa und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Eczema, Hand Dermatoses, Janus Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Dermatologic AgentsEczemaHand DermatosesJanus Kinase InhibitorsHumansChronic DiseaseClinical Trials, Phase III as TopicQuality of LifeSkin CreamTreatment OutcomePyrroles
Substanzen
delgocitinibDermatologic AgentsJanus Kinase InhibitorsPyrroles
Zitieren
APA
Issa, N. T., Yu, J., Bunick, C. G., & Kircik, L. (2025). INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.025412
Vancouver
Issa NT, Yu J, Bunick CG, Kircik L. INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.025412
BibTeX
@article{Issa2025,
author = {Issa, Naiem T and Yu, JiaDe and Bunick, Christopher G and Kircik, Leon},
title = {INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.025412}
}
EUVIMED